Stage IVB Lung Cancer
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC) (NCT06793813) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-01-23 |
| Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer (NCT04005144) | University of California, San Francisco | 2020-02-25 |
Track Stage IVB Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.